MAKO buys partner Pipeline as Stryker deal fuels further acquisition rumors
This article was originally published in Clinica
Robotic surgery specialist MAKO Surgical, which is itself about to be acquired by Stryker, has just agreed to buy partner Pipeline Biomedical’s orthopedic devices and related instruments for around $2.5m and nearly four million MAKO shares. The two companies have worked together since 2010, with Cedar Knolls, New Jersey-based Pipeline developing and supplying “advanced implant technologies” for use with MAKO’s RIO orthopedic system. This included the MAKO-branded Restoris PST cup and tapered stem hip implant system for use with the RIO MAKOplasty total hip arthroplasty software.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.